TIL (STOCKS)
Instil Bio, Inc. Common Stock
$7.260000
-0.220000 (-2.94%)
Prev close: $7.480000
Company Information
- Exchange
- XNAS
- Sector
- Health Technology
- Industry
- Biotechnology
- CEO
- Bronson Crouch
- Asset Type
- stocks
- Website
- Visit
Fundamentals
- Market Cap
- $51.36M
- Employees
- 14
- P/E (TTM)
- -1.03
- P/B (TTM)
- 0.46
- Dividend Yield
- —
Technical Indicators
- SMA 10
- —
- SMA 20
- —
- SMA 50
- —
- EMA 9
- —
- EMA 21
- —
- RSI
- —
- MACD State
- —
Analyst Recommendations
2
Strong Buy
3
Buy
2
Hold
0
Sell
Recent News
No recent news found for this ticker.
Earnings Surprises
| Period | Actual | Estimate | Surprise | Surprise % |
|---|---|---|---|---|
|
Mar 2026 (Q1)
|
$-0.62 | $-0.60 | -0.0241 | -4.04% |
|
Dec 2025 (Q4)
|
$-1.21 | $-2.05 | +0.8369 | +40.89% |
|
Sep 2025 (Q3)
|
$-2.01 | $-2.38 | +0.3686 | +15.50% |
|
Jun 2025 (Q2)
|
$-3.24 | $-2.53 | -0.7125 | -28.19% |
Financial Statements
| Revenues | $0.00 |
| Operating Expenses | $55.03M |
| Operating Income/Loss | -$55.03M |
| Income/Loss From Continuing Operations After Tax | -$47.38M |
| Income/Loss From Continuing Operations Before Tax | -$47.38M |
| Net Income/Loss | -$47.38M |
| Net Income/Loss Attributable To Noncontrolling Interest | $0.00 |
| Net Income/Loss Attributable To Parent | -$47.38M |
| Net Income/Loss Available To Common Stockholders, Basic | -$47.38M |
| Participating Securities, Distributed And Undistributed Earnings/Loss, Basic | $0.00 |
| Preferred Stock Dividends And Other Adjustments | $0.00 |
| Basic Earnings Per Share | -$7.00 |
| Diluted Earnings Per Share | -$7.00 |
| Basic Average Shares | 6,917,586 |
| Diluted Average Shares | 6,917,586 |
| Assets | $200.43M |
| Current Assets | $188.30M |
| Noncurrent Assets | $12.13M |
| Fixed Assets | $112.00K |
| Other Non-current Assets | $12.01M |
| Liabilities | $89.73M |
| Current Liabilities | $4.72M |
| Accounts Payable | $793.00K |
| Wages | $2.25M |
| Other Current Liabilities | $1.68M |
| Noncurrent Liabilities | $85.01M |
| Equity | $110.70M |
| Equity Attributable To Noncontrolling Interest | $0.00 |
| Equity Attributable To Parent | $110.70M |
| Liabilities And Equity | $200.43M |
| Net Cash Flow From Operating Activities | -$33.76M |
| Net Cash Flow From Operating Activities, Continuing | -$33.76M |
| Net Cash Flow From Investing Activities | $15.55M |
| Net Cash Flow From Investing Activities, Continuing | $15.55M |
| Net Cash Flow From Financing Activities | $8.72M |
| Net Cash Flow From Financing Activities, Continuing | $8.71M |
| Exchange Gains/Losses | -$28.00K |
| Net Cash Flow | -$9.52M |
| Net Cash Flow, Continuing | -$9.49M |
| Comprehensive Income/Loss | -$47.10M |
| Comprehensive Income/Loss Attributable To Noncontrolling Interest | $0.00 |
| Comprehensive Income/Loss Attributable To Parent | -$47.10M |
| Other Comprehensive Income/Loss | -$25.71M |
| Other Comprehensive Income/Loss Attributable To Parent | -$81.00K |